Ruth Gallily

4.8k total citations · 1 hit paper
94 papers, 3.9k citations indexed

About

Ruth Gallily is a scholar working on Immunology, Molecular Biology and Pharmacology. According to data from OpenAlex, Ruth Gallily has authored 94 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 24 papers in Molecular Biology and 22 papers in Pharmacology. Recurrent topics in Ruth Gallily's work include Cannabis and Cannabinoid Research (21 papers), Microbial infections and disease research (12 papers) and Immune cells in cancer (9 papers). Ruth Gallily is often cited by papers focused on Cannabis and Cannabinoid Research (21 papers), Microbial infections and disease research (12 papers) and Immune cells in cancer (9 papers). Ruth Gallily collaborates with scholars based in Israel, United States and United Kingdom. Ruth Gallily's co-authors include Raphael Mechoulam, Esther Shohami, Roman Bass, Aviva Yamin, Linda A. Parker, Percy F. Sumariwalla, Marc Feldmann, Evangelos Andreakos, Anne‐Marie Malfait and Michael Zeira and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Ruth Gallily

93 papers receiving 3.7k citations

Hit Papers

The nonpsychoactive cannabis constituent cannabidiol is a... 2000 2026 2008 2017 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Gallily Israel 26 1.9k 875 746 622 512 94 3.9k
Teresa Iuvone Italy 41 3.2k 1.7× 1.2k 1.4× 660 0.9× 1.2k 1.9× 273 0.5× 87 5.8k
Giuseppe Esposito Italy 44 3.0k 1.5× 1.6k 1.9× 370 0.5× 1.2k 1.9× 384 0.8× 161 6.3k
S. H. Ferreira Brazil 29 972 0.5× 892 1.0× 562 0.8× 798 1.3× 139 0.3× 48 3.8k
Carlos Amílcar Parada Brazil 42 676 0.4× 1.6k 1.9× 521 0.7× 1.8k 2.8× 419 0.8× 138 6.3k
Haim Ovadia Israel 38 449 0.2× 1.2k 1.4× 675 0.9× 697 1.1× 297 0.6× 145 4.4k
Sérgio H. Ferreira Brazil 42 704 0.4× 1.4k 1.6× 770 1.0× 1.1k 1.8× 179 0.3× 64 4.8k
Barbara Costa Italy 35 4.5k 2.3× 931 1.1× 456 0.6× 2.7k 4.3× 247 0.5× 68 6.3k
Yuri Persidsky United States 56 736 0.4× 2.4k 2.8× 1.5k 2.0× 968 1.6× 566 1.1× 133 9.7k
Pedro Lorenzo Spain 41 404 0.2× 1.5k 1.7× 727 1.0× 1.0k 1.7× 198 0.4× 184 5.7k
Guy A. Cabral United States 29 2.4k 1.2× 1.6k 1.8× 459 0.6× 1.2k 1.9× 51 0.1× 70 4.6k

Countries citing papers authored by Ruth Gallily

Since Specialization
Citations

This map shows the geographic impact of Ruth Gallily's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Gallily with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Gallily more than expected).

Fields of papers citing papers by Ruth Gallily

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Gallily. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Gallily. The network helps show where Ruth Gallily may publish in the future.

Co-authorship network of co-authors of Ruth Gallily

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Gallily. A scholar is included among the top collaborators of Ruth Gallily based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Gallily. Ruth Gallily is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gallily, Ruth, et al.. (2018). Avidekel Cannabis extracts and cannabidiol are as efficient as Copaxone in suppressing EAE in SJL/J mice. Inflammopharmacology. 27(1). 167–173. 17 indexed citations
2.
Fisher, Tamar, Hana Golan, Ginette Schiby, et al.. (2016). In Vitro and In Vivo Efficacy of Non-Psychoactive Cannabidiol in Neuroblastoma. Current Oncology. 23(11). 15–22. 57 indexed citations
3.
Fisher, Tamar, J. Shoham, Ruth Gallily, et al.. (2008). Δ9-Tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells. Acta Oncologica. 47(6). 1062–1070. 47 indexed citations
4.
Weiss, Lola, Michael Zeira, Shimon Slavin, et al.. (2007). Cannabidiol arrests onset of autoimmune diabetes in NOD mice. Neuropharmacology. 54(1). 244–249. 117 indexed citations
5.
6.
Moussaieff, Arieh, Ester Fride, Zohar Amar, et al.. (2005). The Jerusalem Balsam: From the Franciscan Monastery in the old city of Jerusalem to Martindale 33. Journal of Ethnopharmacology. 101(1-3). 16–26. 28 indexed citations
7.
Weiss, Lola, Michael Zeira, S Reich, et al.. (2005). Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity. 39(2). 143–151. 179 indexed citations
8.
Sumariwalla, Percy F., Ruth Gallily, Susanna Tchilibon, et al.. (2004). A novel synthetic, nonpsychoactive cannabinoid acid (HU‐320) with antiinflammatory properties in murine collagen‐induced arthritis. Arthritis & Rheumatism. 50(3). 985–998. 111 indexed citations
9.
Godin, Biana, et al.. (2003). Cannabidiol—transdermal delivery and anti-inflammatory effect in a murine model. Journal of Controlled Release. 93(3). 377–387. 198 indexed citations
10.
Trembovler, Victoria, Elie Beit‐Yannai, Firas Younis, et al.. (1999). Antioxidants Attenuate Acute Toxicity of Tumor Necrosis Factor-alpha Induced by Brain Injury in Rat. Journal of Interferon & Cytokine Research. 19(7). 791–795. 50 indexed citations
11.
Engelhard, Dan, Shlomo Pomeranz, Ruth Gallily, Nurith Strauss, & Elaine Tuomanen. (1997). Serotype‐Related Differences in Inflammatory Response toStreptococcus pneumoniaein Experimental Meningitis. The Journal of Infectious Diseases. 175(4). 979–982. 44 indexed citations
12.
Shohami, Esther, Roman Bass, David Wallach, Aviva Yamin, & Ruth Gallily. (1996). Inhibition of Tumor Necrosis Factor Alpha (TNFα) Activity in Rat Brain is Associated with Cerebroprotection after Closed Head Injury. Journal of Cerebral Blood Flow & Metabolism. 16(3). 378–384. 235 indexed citations
13.
Sher, Talia, Shlomo Rottem, & Ruth Gallily. (1990). Mycoplasma capricolum membranes induce tumor necrosis factor α by a mechanism different from that of lipopolysaccharide. Cancer Immunology Immunotherapy. 31(2). 86–92. 41 indexed citations
14.
Sionov, Ronit Vogt & Ruth Gallily. (1990). Engulfment and intracellular killing of F9 teratocarcinoma cells by non-activated murine macrophages. International Immunology. 2(4). 291–301. 9 indexed citations
15.
Sher, Talia, et al.. (1990). Partial biochemical characterization of spiroplasma membrane component inducing tumor necrosis factor. Anti-Cancer Drugs. 1(1). 83–88. 6 indexed citations
16.
Gifford, George E., et al.. (1989). Production of a Factor (CIF) from Normal Fibroblast Cells Inhibiting Tumor Necrosis Factor/Cachectin Production. Experimental Biology and Medicine. 191(4). 391–395. 1 indexed citations
17.
Gallily, Ruth, et al.. (1989). Tumor necrosis factor as a mediator of Mycoplasma orale-induced tumor cell lysis by macrophages. Cellular Immunology. 121(1). 146–153. 32 indexed citations
18.
Zeira, Michael & Ruth Gallily. (1988). Interaction between thymocytes and thymus-derived macrophages. Cellular Immunology. 117(2). 277–288. 11 indexed citations
19.
Bercovici, B & Ruth Gallily. (1978). The cytology of the retained IUD with relation to the mechanism of action.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 22(6). 456–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026